0001209191-23-026991.txt : 20230503
0001209191-23-026991.hdr.sgml : 20230503
20230503164420
ACCESSION NUMBER: 0001209191-23-026991
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230501
FILED AS OF DATE: 20230503
DATE AS OF CHANGE: 20230503
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bhatia Sangeeta N.
CENTRAL INDEX KEY: 0001643921
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 23884883
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS, INC.
STREET 2: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-05-01
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001643921
Bhatia Sangeeta N.
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
0
0
0
1
Common Stock
2023-05-01
4
A
0
1168
0.00
A
5208
D
Common Stock
2023-05-02
4
S
0
62
345.93
D
5146
D
Common Stock
2023-05-02
4
S
0
172
346.69
D
4974
D
Common Stock
2023-05-02
4
S
0
120
348.16
D
4854
D
Common Stock
2023-05-02
4
S
0
163
349.82
D
4691
D
Common Stock
2023-05-02
4
S
0
63
351.20
D
4628
D
Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date.
Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1, which was entered into on 05/17/2022.
Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $345.93 (range $345.20 to $346.12).
Open market sales reported on this line occurred at a weighted average price of $346.69 (range $346.31 to $347.03).
Open market sales reported on this line occurred at a weighted average price of $348.16 (range $347.91 to $348.64).
Open market sales reported on this line occurred at a weighted average price of $349.82 (range $349.17 to $350.08).
Open market sales reported on this line occurred at a weighted average price of $351.20 (range $350.92 to $351.48).
/s/ Christiana Stevenson, Attorney-in-Fact
2023-05-03